{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:24:27Z","timestamp":1773422667274,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jpba.2015.09.027","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T21:42:46Z","timestamp":1443303766000},"page":"436-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A validated LC\/UV method for the determination of four adulterating drugs in herbal slimming capsules"],"prefix":"10.1016","volume":"117","author":[{"given":"Giacomo","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2964-389X","authenticated-orcid":false,"given":"Lucia","family":"Grumetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.09.027_bib0005","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-2125.2010.03822.x","article-title":"Case Series on a diversity of illicit weight-reducing agents: from the well known to the unexpected","volume":"71","author":"Tang","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2015.09.027_bib0010","first-page":"11","article-title":"Herbal formulations as pharmacotherapeutic agents","volume":"40","author":"Kuruvilla","year":"2002","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.jpba.2015.09.027_bib0015","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1365-2125.2006.02684.x","article-title":"Herbal product\u2013drug interactions mediated by induction","volume":"61","author":"Tirona","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2015.09.027_bib0020","unstructured":"WHO, Sixty-second World Health Assembly Item 12.9: counterfeit medical products, 2009, http:\/\/aps.who.int\/gb\/ebhwa\/pdf_files\/A62\/A62_13-en.pdf."},{"key":"10.1016\/j.jpba.2015.09.027_bib0025","unstructured":"European Parlement, 2011, http:\/\/www.europarl.europe.eu\/sides\/get Doc.do?pubRef=-\/\/EP\/\/TEXT+TA+P7-TA-2011-0056+0+DOC+XML+V0\/\/EN (accessed 14.04.11)."},{"key":"10.1016\/j.jpba.2015.09.027_bib0030","unstructured":"WHO, Sixty-second World Health Assembly Item 12.9: counterfeit medical products, 2009, http:\/\/aps.who.int\/gb\/ebhwa\/pdf_files\/A62\/A62_13-en.pdf."},{"key":"10.1016\/j.jpba.2015.09.027_bib0035","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1080\/19440049.2013.800649","article-title":"Determination of diuretics and laxatives as adulterants in herbal formulations for weight loss","volume":"30","author":"Moreira","year":"2013","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.jpba.2015.09.027_bib0040","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.5812\/ircmj.15344","article-title":"Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements","volume":"16","author":"Khazan","year":"2014","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.jpba.2015.09.027_bib0045","unstructured":"Ministero della Salute\u2014Decreto 27 luglio 2015\u2014Gazzetta Ufficiale della Repubblica Italiana\u2014Serie Generale n. 175 30.07.15."},{"key":"10.1016\/j.jpba.2015.09.027_bib0050","unstructured":"Ministero della Salute - Decreto 4 agosto 2015 - Gazzetta Ufficiale della Repubblica Italiana\u2014Serie Generale n. 184 10.08.15."},{"issue":"9492","key":"10.1016\/j.jpba.2015.09.027_bib0055","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2015.09.027_bib0060","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4103\/0976-500X.85942","article-title":"Benfluorex withdrawal in France: still be hiding somewhere in the world?","volume":"2","author":"Frachon","year":"2011","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.jpba.2015.09.027_bib0065","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/dmr.5610090509","article-title":"Mechanisms for the effects of benfluorex on the obese\u2013diabetic\u2013dyslipidemic syndrome","volume":"9","author":"Brindley","year":"1993","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.jpba.2015.09.027_bib0070","series-title":"Treatment of the Obese Patient (Contemporary Endocrinology)","first-page":"p. 158","author":"Kushner","year":"2007"},{"key":"10.1016\/j.jpba.2015.09.027_bib0075","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/bja\/85.1.91","article-title":"Obesity in anaesthesia and intensive care","volume":"85","author":"Adams","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2015.09.027_bib0080","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1183\/09031936.00086308","article-title":"Fenfluramine-like cardiovascular side-effects of benfluorex","volume":"33","author":"Boutet","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jpba.2015.09.027_bib0085","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1472-8206.2006.00441.x","article-title":"Valvular heart disease in a patient taking benfluorex","volume":"20","author":"Noize","year":"2006","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2015.09.027_bib0090","series-title":"European Union, London TAS-CAS (2009)","author":"EMEA","year":"2009"},{"key":"10.1016\/j.jpba.2015.09.027_bib0095","unstructured":"World Anti-Doping Agency (2010) The 2010 Prohibited List, http:\/\/www.wada-ama.org\/Documents\/World_Anti-Doping_Program\/WADP-Prohibited-list\/WADA_Prohibited_List_2010_EN.pdf, 14.01.10"},{"key":"10.1016\/j.jpba.2015.09.027_bib0100","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jps.2600790517","article-title":"Influence of hydrophobicity on the ion exchange selectivity coefficients for aromatic amines","volume":"79","author":"Kril","year":"1990","journal-title":"J. Pharm. Sci."},{"issue":"1 July","key":"10.1016\/j.jpba.2015.09.027_bib0105","first-page":"221","article-title":"Comparison of the metabolic and endocrine effects of 3,5,3\u2032-triiodothyroacetic acid and thyroxine","volume":"77","author":"Bracco","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jpba.2015.09.027_bib0110","unstructured":"http:\/\/www.lilly.ca\/en\/pdf\/product-monograph\/27_prozac-pm_20sep2013.pdf."},{"key":"10.1016\/j.jpba.2015.09.027_bib0115","unstructured":"http:\/\/www.merckvetmanual.com\/mvm\/toxicology\/toxicities_from_human_drugs\/\/decongestants_toxicity.html, 2015."},{"key":"10.1016\/j.jpba.2015.09.027_bib0120","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed pharmacological effects of antidepressants","volume":"7","author":"Frazer","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpba.2015.09.027_bib0125","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.diabet.2011.04.001","article-title":"Benfluorex: analysis of a drug-related public health crisis","volume":"37","author":"Menard","year":"2011","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.jpba.2015.09.027_bib0130","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1467-789X.2006.00195.x","article-title":"Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update","volume":"7","author":"Haaz","year":"2006","journal-title":"Obes. Rev."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T21:06:05Z","timestamp":1567199165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515301680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":26,"alternative-id":["S0731708515301680"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.09.027","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated LC\/UV method for the determination of four adulterating drugs in herbal slimming capsules","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}